For the first time in Korea, beginning with the localization of dental implants, the company has been leading the biomedical industry with its rhBMP-2 fusion technology.

Cowellmedi succeeded in developing implant for the first time in Korea in 1994 and was medaled for its achievement from the government of Korea.

In 2010, Cowellmedi attracted the world’s attention once again by successfully developing E.rhBMP-2 (a growth factor) for the first time in the world. That led Cowellmedi to become a global company in the biomedical field.